Caffeine, coffee linked to lower cardiometabolic multimorbidity risk
By
HealthDay News
Sep 18, 2024
Habitual caffeine or coffee intake, especially at moderate levels, was linked to a lower risk for new-onset cardiometabolic multimorbidity, which was defined as the coexistence of at least two of type...
High, long-term consumption of caffeine may pose cardiovascular risk
By
Haymarket Media
Aug 30, 2024
An impaired recovery of heart rate and blood pressure following physical exertion was seen in healthy adults.
Eating more fruits, vegetables tied to lower blood pressure
Aug 06, 2024
Additional benefits include improved kidney and heart health in patients with hypertension.
Study looks at effects of reducing intake of processed meat, unprocessed red meat
Jul 29, 2024
A 30% reduction in processed meat intake would lead to 352,900 fewer occurrences of type 2 diabetes and 92,500 fewer occurrences of cardiovascular disease.
Certain diets may protect against heart disease with type 1 diabetes
Jul 16, 2024
Higher adherence was tied to lower inflammatory marker levels over time.
Fish oil beneficial for reducing risk for cardiovascular disease progression
May 22, 2024
However, supplements may be a risk factor for atrial fibrillation and stroke in the general population.
Less than one-quarter of patients hospitalized for CVD receive dietary counseling
Jun 18, 2024
The findings were seen across hospitalizations for acute myocardial infarction, congestive heart failure and percutaneous coronary intervention.
Xylitol linked to incident major adverse cardiovascular event risk
Jun 17, 2024
The sweetener xylitol was linked to incident major adverse cardiovascular event risk in an initial untargeted metabolomics study and was confirmed in a validation cohort.
Up to 30 percent of CVD mortality attributable to excess salt intake
Mar 29, 2024
The population-attributable risk estimates suggest that sodium above the recommended intake is linked to 10 to 30% of CVD mortality.
Salt substitution may reduce all-cause, cardiovascular mortality
Apr 08, 2024
A slight reduction was seen in major cardiovascular events; very low certainty of serious adverse events was reported.